Usana Health Sciences (USNA) Capital Expenditures (2016 - 2026)
Usana Health Sciences has reported Capital Expenditures over the past 16 years, most recently at $2.6 million for Q2 2026.
- Quarterly Capital Expenditures rose 8432.26% to $2.6 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $16.4 million through Apr 2026, up 164470.0% year-over-year, with the annual reading at $13.8 million for FY2026, 32811.9% up from the prior year.
- Capital Expenditures was $2.6 million for Q2 2026 at Usana Health Sciences, down from $2.8 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $13.1 million in Q4 2023 and troughed at -$13.2 million in Q1 2022.
- The 5-year median for Capital Expenditures is $225500.0 (2023), against an average of $1.0 million.
- Year-over-year, Capital Expenditures tumbled 178.14% in 2023 and then skyrocketed 8432.26% in 2026.
- A 5-year view of Capital Expenditures shows it stood at -$5.9 million in 2022, then skyrocketed by 323.99% to $13.1 million in 2023, then tumbled by 100.45% to -$59000.0 in 2024, then skyrocketed by 18684.75% to $11.0 million in 2025, then plummeted by 75.88% to $2.6 million in 2026.
- Per Business Quant, the three most recent readings for USNA's Capital Expenditures are $2.6 million (Q2 2026), $2.8 million (Q1 2026), and $11.0 million (Q3 2025).